C4IP Urges Senate Judiciary to Ignore Common Myths About Drug Patents
[/ipw_quote]“‘Evergreening’ and ‘patent thicketing’ aren’t keeping cheaper generics out of patients’ hands.” – C4IP[/ipw_quote] On May 20, the Council for Innovation Promotion (C4IP) sent a letter addressed to the U.S. Senate Committee on the Judiciary one day before the committee…